Anticipating Heterogeneity in Rate of Dystrophy to Prepare for Endpoint Variation & Optimize Trial Design
3:45 pm - Thursday 28th January 2027
- Characterizing differences in disease progression trajectories across patient populations to improve endpoint selection
- Designing adaptive and risk-adjusted clinical trial strategies that account for heterogeneous decline patterns and maximize the likelihood of detecting treatment effects
